Premium
Elevation Oncology Inc (ELEV)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be th... Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0355 | -5.51071095933 | 0.6442 | 0.6925 | 0.59 | 1265625 | 0.63631083 | CS |
| 4 | -0.1673 | -21.5592783505 | 0.776 | 0.7919 | 0.585 | 1659496 | 0.66206438 | CS |
| 12 | 0.0296 | 5.11137972716 | 0.5791 | 0.98 | 0.5451 | 2181742 | 0.69855855 | CS |
| 26 | -0.1813 | -22.9493670886 | 0.79 | 0.98 | 0.5 | 1379931 | 0.67661387 | CS |
| 52 | -2.4513 | -80.1078431373 | 3.06 | 5.8299 | 0.5 | 1206107 | 1.68653392 | CS |
| 156 | -3.1613 | -83.8541114058 | 3.77 | 5.89 | 0.363 | 920076 | 2.2697983 | CS |
| 260 | -13.3913 | -95.6521428571 | 14 | 16.22 | 0.363 | 770449 | 2.37218989 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
